| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Kernforschungszentrum Karlsruhe, Institut für Genetik und Toxikologie [M. H., C. T., H. P., P. H.], Universität Karlsruhe, Institut für Genetik [W. R., P. H., U. G.], D-7500 Karlsruhe 1, and Deutsches Krebsforschungszentrum Heidelberg, Institut für Radiologie und Pathophysiologie, Im Neuenheimer Feld 280 [M. Z.], D-6900 Heidelberg 1, Federal Republic of Germany
One of several splice variants of CD44 expressed in metastasizing cell lines of rat tumors has been shown to confer metastatic potential to the non-metastatic variant of a rat pancreatic carcinoma line (U. Günthert et al., Cell, 65: 13–24, 1991). The variant-specific rat CD44 sequences were used to detect RNA expression in human cell lines: in carcinoma lines from lung, breast and colon; and in keratinocyte lines.
By polymerase chain reaction amplification, complementary DNAs encoding human homologues were isolated and sequenced. The largest splice variant has been found in a large cell lung carcinoma line and in keratinocyte cell lines. It carries at least 5 additional domains (exons) encoding a total of 338 amino acids in the membrane-proximal extracellular region of the standard CD44. Various alternative splice products have been detected in other human tumor cell lines. The distribution of CD44 splice variants is consistent with the speculation that they fulfill functions in only a few restricted differentiation pathways and that in tumor cells these pathways have been reactivated.
1 This investigation was supported by Deutsche Forschungsgemeinschaft Grants Gü 249/1-1 to U. G. and He 551/6-1 to U. G., P. H., H. P., and M. Z.
Received 4/ 2/91. Accepted 7/16/91.
This article has been cited by other articles:
|
|
 |
|
  D. NAOR, S. NEDVETZKI, M. WALMSLEY, A. YAYON, E. A. TURLEY, I. GOLAN, D. CASPI, L. E. SEBBAN, Y. ZICK, T. GARIN, et al. CD44 Involvement in Autoimmune Inflammations: The Lesson to be Learned from CD44-Targeting by Antibody or from Knockout Mice Ann. N.Y. Acad. Sci., September 1, 2007; 1110(1): 233 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Eshkar Sebban, D. Ronen, D. Levartovsky, O. Elkayam, D. Caspi, S. Aamar, H. Amital, A. Rubinow, I. Golan, D. Naor, et al. The Involvement of CD44 and Its Novel Ligand Galectin-8 in Apoptotic Regulation of Autoimmune Inflammation J. Immunol., July 15, 2007; 179(2): 1225 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kuhn, M. Koch, T. Nubel, M. Ladwein, D. Antolovic, P. Klingbeil, D. Hildebrand, G. Moldenhauer, L. Langbein, W. W. Franke, et al. A Complex of EpCAM, Claudin-7, CD44 Variant Isoforms, and Tetraspanins Promotes Colorectal Cancer Progression Mol. Cancer Res., June 1, 2007; 5(6): 553 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Napier, Z. R. Healy, R. L. Schnaar, and K. Konstantopoulos Selectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells: THE ROLES OF CD44V AND ALTERNATIVE SIALOFUCOSYLATED SELECTIN LIGANDS J. Biol. Chem., February 9, 2007; 282(6): 3433 - 3441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Matzke, P. Herrlich, H. Ponta, and V. Orian-Rousseau A Five-Amino-Acid Peptide Blocks Met- and Ron-Dependent Cell Migration Cancer Res., July 15, 2005; 65(14): 6105 - 6110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. D. Hanley, M. M. Burdick, K. Konstantopoulos, and R. Sackstein CD44 on LS174T Colon Carcinoma Cells Possesses E-Selectin Ligand Activity Cancer Res., July 1, 2005; 65(13): 5812 - 5817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Urquidi, D. Sloan, K. Kawai, D. Agarwal, A. C. Woodman, D. Tarin, and S. Goodison Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis Clin. Cancer Res., January 1, 2002; 8(1): 61 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohene-Abuakwa and M. Pignatelli Adhesion Molecules as Diagnostic Tools in Tumor Pathology International Journal of Surgical Pathology, July 1, 2000; 8(3): 191 - 200. [Abstract] [PDF]
|
|
|
|
 |
|
 T Gotoda, Y Matsumura, H Kondo, H Ono, A Kanamoto, H Kato, H Watanabe, Y Tachimori, Y Nakanishi, and T Kakizoe Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma Gut, January 1, 2000; 46(1): 14 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Bell, A. E. Cowper, M.-P. Lefranc, J. I. Bell, and G. R. Screaton Influence of Intron Length on Alternative Splicing of CD44 Mol. Cell. Biol., October 1, 1998; 18(10): 5930 - 5941. [Abstract] [Full Text]
|
|
|
|
|
|
W Reinisch, K-H Heider, G Oberhuber, C Dejaco, M Mullner, G R Adolf, and C Gasche Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease Gut, September 1, 1998; 43(3): 375 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sherman, D. Wainwright, H. Ponta, and P. Herrlich A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth Genes & Dev., April 1, 1998; 12(7): 1058 - 1071. [Abstract] [Full Text]
|
|
|
|
|
|
L. Y. W. Bourguignon, H. Zhu, A. Chu, N. Iida, L. Zhang, and M.-C. Hung Interaction between the Adhesion Receptor, CD44, and the Oncogene Product, p185HER2, Promotes Human Ovarian Tumor Cell Activation J. Biol. Chem., October 31, 1997; 272(44): 27913 - 27918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Griffioen, M. J.H. Coenen, C. A. Damen, S. M.M. Hellwig, D. H.J. van Weering, W. Vooys, G. H. Blijham, and G. Groenewegen CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells Blood, August 1, 1997; 90(3): 1150 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Taylor, C. Gercel-Taylor, and S. A. Gall Expression and Shedding of CD44 Variant Isoforms in Patients With Gynecologic Malignancies Reproductive Sciences, September 1, 1996; 3(5): 289 - 294. [Abstract] [PDF]
|
|
|
|
|
|
K. Takahashi, I. Stamenkovic, M. Cutler, A. Dasgupta, and K. K. Tanabe Keratan Sulfate Modification of CD44 Modulates Adhesion to Hyaluronate J. Biol. Chem., April 19, 1996; 271(16): 9490 - 9496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Telen, M. Udani, M. K. Washington, M. C. Levesque, E. Lloyd, and N. Rao A Blood Group-related Polymorphism of CD44 Abolishes a Hyaluronan-binding Consensus Sequence without Preventing Hyaluronan Binding J. Biol. Chem., March 22, 1996; 271(12): 7147 - 7153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Goebeler, D Kaufmann, E. Brocker, and C. Klein Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors J. Cell Sci., January 7, 1996; 109(7): 1957 - 1964. [Abstract] [PDF]
|
|
|
|
|
|
D. Hudson, J Sleeman, and F. Watt CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion J. Cell Sci., January 5, 1995; 108(5): 1959 - 1970. [Abstract] [PDF]
|
|
|
|
|
|
A Bartolazzi, D Jackson, K Bennett, A Aruffo, R Dickinson, J Shields, N Whittle, and I Stamenkovic Regulation of growth and dissemination of a human lymphoma by CD44 splice variants J. Cell Sci., January 4, 1995; 108(4): 1723 - 1733. [Abstract] [PDF]
|
|
|
|
 |
|
 Y Matsumura, D Hanbury, J Smith, and D Tarin Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells BMJ, March 5, 1994; 308(6929): 619 - 624. [Abstract] [Full Text]
|
|
|
|
 |
|
 D H van Weering, P D Baas, and J L Bos A PCR-based method for the analysis of human CD44 splice products. Genome Res., October 1, 1993; 3(2): 100 - 106. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Wheatley, C. Isacke, and P. Crossley Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning Development, January 10, 1993; 119(2): 295 - 306. [Abstract] [PDF]
|
|
|
|
|
|
S. Kennel, T. Lankford, L. Foote, S. Shinpock, and C Stringer CD44 expression on murine tissues J. Cell Sci., January 2, 1993; 104(2): 373 - 382. [Abstract] [PDF]
|
|
|
|
 |
|
 R Arch, K Wirth, M Hofmann, H Ponta, S Matzku, P Herrlich, and M Zoller Participation in normal immune responses of a metastasis-inducing splice variant of CD44 Science, July 31, 1992; 257(5070): 682 - 685. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
